The Effect of Faecal Enema on Five Microflora-Associated Characteristics in Patients with Antibiotic-Associated Diarrhoea

References

• Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257–62.
   PubMed Web of Science ®Google Scholar
• Nord CE, Edlund C. Ecological effects of antimicrobial agents on the human intestinal microflora. Microb Ecol Health Dis 1991;4:193–207.
   Google Scholar
• Bartlett JG. Antibiotic-associated diarrhoea. Clin Infect Dis 1992;15:573–81.
   PubMed Web of Science ®Google Scholar
• Midtvedt T, Carlstedt-Duke B, H0verstad T, Lingaas E, Norin KE, Saxerholt H, et al. Influence of peroral antibiotics upon the biotransformatory activity of the intestinal microflora in healthy subjects. Eur J Clin Invest 1986;16:11–7.
   PubMed Web of Science ®Google Scholar
• Steinbakk M, Lingaas E, Carlstedt-Duke B, Høverstad T, Midtvedt A-C, Norin KE, et al. Faecal concentration of ten antibiotics and influence on some microflora-associated characteristics (MACs). Microb Ecol Health Dis 1992;5:269–76.
   Google Scholar
• Hove H, Tvede M, Mortensen PB. Antibiotic-associated diarrhoea, Clostridium difficile, and short-chain fatty acids. Scand J Gastroenterol 1996;31: 688–93.
   PubMed Web of Science ®Google Scholar
• Midtvedt T. Microflora-associated characteristics (MACs) and germfree animal characteristics (GACs) in man and animals. Microecol Ther 1985;15:295–302.
   Google Scholar
• Midtvedt T. Influence of antibiotics on biochemical intestinal microflora-associated characteristics in man and animals. In: Gillissen G, Opferkuch W, Peters G, Pulverer G, editors. The influence of antibiotics on the host-parasite relationship. III. Berlin: Springer-Verlag; 1989. p. 209–15.
   Google Scholar
• Andréasson K, Norin KE, Midtvedt T. Influence of ampicillin, clindamycin or metronidazol upon the 7α-dehydroxylation of bile acids in the human intestine. Curr Microbiol 1988;6: 329–31.
   Google Scholar
• Gustafsson A, Lund-Tønnesen S, Berstad A, Midtvedt T, Norin E. Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment. Scand J Gastroenterol 1998;33:721–7.
   PubMed Web of Science ®Google Scholar
• Midtvedt AC, Carlstedt-Duke B, Norin KE, Saxerholt H, Midtvedt T. Development of five metabolic activities associated with the intestinal microflora of healthy infants. J Ped Gastroenterol Nutr 1988;7:559–67.
   PubMed Web of Science ®Google Scholar
• Midtvedt T, Carlstedt-Duke B, H0verstad T, Midtvedt AC, Norin KE, Saxerholt H. Establishment of a biochemically active intestinal ecosystem in ex-germfree rats. Appl Environ Microb 1987;53:2866–71.
   PubMed Web of Science ®Google Scholar
• Collinder E, Lindholm A, Midtvedt T, Norin E. Intestinal biochemical microbial functions in the horse. Equine Vet J. In press, 1999.
   Google Scholar
• Midtvedt T, Lingaas E, Carlstedt-Duke B, Høverstad T, Midtvedt A-C, Saxerholt H, et al. Intestinal microbial conversion of cholesterol to coprostanol in man. APMIS 1990;98:839–44.
   Google Scholar
• Lichtenstien AH. Intestinal cholesterol metabolism. Ann Med 1990;22:49–52.
   PubMedGoogle Scholar
• Midtvedt AC, Midtvedt T. Conversion of cholesterol to coprostanol by the intestinal microflora during the first two years of human life. J Ped Gastroenterol Nutr 1993;17:161–8.
   PubMed Web of Science ®Google Scholar
• Freier TA, Beitz DC, Li L, Hartman PA. Characterization of Eubacterium coprostanoligenes sp.nov., a cholesterol-reducing anaerobe. Int J Syst Bacteriol 1994;44: 137–42.
   PubMedGoogle Scholar
• Ren D, Li L, Schwabacher AW, Young JW, Beitz DC. Mechanism of cholesterol reduction to coprostanol by Eubacterium coprostanoligenes ATCC 51222. Steroids 1996;61: 33–40.
   PubMed Web of Science ®Google Scholar
• Sadzikowski MR, Sperry JF, Wilkins TD. Cholesterol-reducing bacterium from human feces. Appl Environ Microbiol 1997;34: 355–62.
   Google Scholar
• Saxerholt H, Carlstedt-Duke B, Høverstad T, Lingaas E, Norin KE, Steinbakk M, et al. Influence of antibiotics on the faecal excretion of bile pigments in healthy subjects. Scand J Gastroenterol 1986;21:991–6.
   PubMed Web of Science ®Google Scholar
• Gadelle D, Raibaud P, Sacquet E. β-Glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats. Appl Environ Microbiol 1985;49:682–5.
   Google Scholar
• Cole CB, Fuller R, Mallet AK, Rowland IR. The influence ofthe host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds. J Appl Bact 1985;59:549–63.
   PubMedGoogle Scholar
• Midtvedt T, Gustafsson BE. Microbial conversion of bilirubin to urobilins in vitro and in vivo. Acta Pathol Microbiol Immunol Scand [B] 1981;89:57–60.
   Google Scholar
• Gustafsson A, Norin E, Midtvedt T. Establishment of some microflora-associated characteristics in ex-germfree rats and the developmental pattern. Scand J Lab Animal Sci 1996;23:109–16.
   Google Scholar
• Ramare F, Hautefort I, Verhe F, Raibaud P, Iovanna J. Inactivation of tryptic activity by a human-derived strain of Bacteroides distasonis in the large intestines of gnotobiotic rats and mice. Appl Environ Microbiol 1996;62:1434–6.
   Google Scholar
• Carlstedt-Duke B, Midtvedt T, Nord CE, Gustafsson BE. Isolation and characterization of a mucin-degrading strain of Peptostreptococcus from rat intestinal tract. Acta Pathol Microbiol Immunol Scand [B] 1986;94: 293–300.
   PubMedGoogle Scholar
• Hoskins LC. Bacterial glycosidases and degradation of glyco-conjugates in the human gut. In: Wadström T, Mäkelä PH, Svennerholm A-M, Wolf-Watz H, editors. Molecular pathogenesis of gastrointestinal infections. New York: Plenum Press; 1991. p. 37–47.
   Google Scholar
• Carlstedt-Duke B, Høverstad T, Lingaas E, Norin KE, Saxerholt H, Steinbakk M, et al. Influence of antibiotics on intestinal mucin in healthy subjects. Eur J Clin Microbiol 1986;5:634–8.
   PubMedGoogle Scholar
• Bowden TA, Mansberger A, Lykins L. Pseudomembranous enterocolitis: mechanism of restoring floral homeostasis. Am Surg 1981;47:178–83.
   Google Scholar
• Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984;16:211–5.
   PubMed Web of Science ®Google Scholar
• Schwan A, Sjölin S, Trottestam U, Aronson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983;10:845.
   Google Scholar
• Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989;1: 1156–60.
   PubMed Web of Science ®Google Scholar